Cyber Resilience

CVE-2024-7226

CSRF in Oretnom23 Medicine Tracker System 1.0

Public PoCCSRF
Published
30 July 2024
Modified
21 November 2024
CVSS Score v4 6.9
Click a component to see what it means
Raw vectorCVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:L/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
EPSS Score 0.0040 33th percentile
Risk Priority 41 floored blend · peak EPSS

Summary

CVE-2024-7226 is a medium-severity CSRF (CWE-352) vulnerability in Oretnom23 Medicine Tracker System. Its CVSS base score is 6.9 (Medium).

Operationally, exploitation aligns with the MITRE ATT&CK technique Exploit Public-Facing Application (T1190); ranked at the 33th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog; a public proof-of-concept is referenced.

The strongest mitigations our analysis identified map to AC-3 (Access Enforcement) and SC-23 (Session Authenticity) — see the control section below for these in your framework.

OWASP Top 10 for Web (2025)

EU & UK References

Vulnerability Data

A vulnerability was found in SourceCodester Medicine Tracker System 1.0. It has been declared as problematic. This vulnerability affects unknown code of the file /classes/Users.php?f=save_user of the component Password Change Handler. The manipulation leads to cross-site request forgery. The attack…

more

can be initiated remotely. The exploit has been disclosed to the public and may be used. VDB-272806 is the identifier assigned to this vulnerability.

CWE(s)

Related Threats

MITRE ATT&CK Enterprise Techniques

T1190 Exploit Public-Facing Application Initial Access
Adversaries may attempt to exploit a weakness in an Internet-facing host or system to initially access a network.
Derived from this CVE’s CWE(s) via the direct CWE→ATT&CK cross-walk.

CVEs Like This One

CVE-2024-7661Same vendor: Oretnom23
CVE-2024-57523Same vendor: Oretnom23
CVE-2024-4929Same vendor: Oretnom23
CVE-2024-7169Same vendor: Oretnom23
CVE-2024-7645Same vendor: Oretnom23
CVE-2024-5428Same vendor: Oretnom23
CVE-2023-27073Same vendor: Oretnom23
CVE-2024-7662Same vendor: Oretnom23
CVE-2024-6649Same vendor: Oretnom23
CVE-2024-7367Same vendor: Oretnom23

Affected Assets

oretnom23
medicine tracker system
1.0

Mitigating Controls

Control response

Prevent
Stop it (NIST 800-53)

Detect
Catch it (NIST detect / respond)

Harden
Shrink the surface (DISA STIG)

Validate
Prove the fix (OWASP ASVS)
  • V3.3.2
  • V3.5.1
  • V10.2.1

Mitigating Controls (NIST 800-53 r5) AI

Access enforcement requires verifying that state-changing requests originate from the authenticated user rather than a forged cross-site source.

Protecting session authenticity prevents attackers from replaying or forging authenticated requests via the victim's browser.

Mitigating Controls (NIST CSF 2.0) AI

Derived directly from the weakness types (CWEs) cited in the NVD entry via our AI-authored CWE→CSF cross-walk (authority under review) — links open the control.

PR.PS-06 mostly match
prevents

Secure SDLC practices directly require anti-CSRF controls such as tokens or SameSite attributes.

Mitigating Controls (ISO/IEC 27001:2022 Annex A) AI

Derived directly from the weakness types (CWEs) cited in the NVD entry via our AI-authored CWE→ISO cross-walk (authority under review) — links open the control.

mitigates

By denying access to phishing or malicious sites, the control lowers the likelihood that a user will be tricked into submitting a forged request that performs an unintended action on another site.

none

Contextual intelligence about emerging CSRF toolkits can be translated into updated anti-CSRF token or same-site policy configurations across applications.

References